{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:28:30Z","timestamp":1791106110819,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.nbd.2007.07.009","type":"journal-article","created":{"date-parts":[[2007,7,25]],"date-time":"2007-07-25T07:18:39Z","timestamp":1185347919000},"page":"197-205","source":"Crossref","is-referenced-by-count":60,"title":["Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington\u2019s disease mice"],"prefix":"10.1016","volume":"28","author":[{"given":"M.R.","family":"Domenici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Scattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Martire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lastoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Borioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Venerosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Calamandrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Popoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2007.07.009_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"15","author":"Anderson","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2007.07.009_bib2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1021\/jm950746l","article-title":"Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A2a adenosine antagonists","volume":"39","author":"Baraldi","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2007.07.009_bib3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington\u2019s disease","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.07.009_bib4","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate\u2013glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2007.07.009_bib5","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","article-title":"A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists","volume":"23","author":"Blum","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.07.009_bib6","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.07.009_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington\u2019s disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2007.07.009_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse model of Huntington\u2019s disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond., B"},{"key":"10.1016\/j.nbd.2007.07.009_bib9","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","article-title":"A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice","volume":"19","author":"Chen","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.07.009_bib10","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","article-title":"cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues","volume":"280","author":"Chiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2007.07.009_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS 21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.07.009_bib12","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0705185","article-title":"Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity","volume":"138","author":"Dall\u2019Igna","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"11 Suppl 6","key":"10.1016\/j.nbd.2007.07.009_bib46","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1212\/01.WNL.0000095220.87550.F6","article-title":"Adenosine A2A receptor and depression","volume":"61","author":"El Yacoubi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2007.07.009_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine\u2013dopamine receptor\u2013receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e8","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2007.07.009_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(98)00736-7","article-title":"Striking changes in anxiety in Huntington\u2019s disease transgenic mice","volume":"805","author":"File","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2007.07.009_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.02145.x","article-title":"Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage","volume":"88","author":"Fink","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.07.009_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2007.07.009_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine adenosine and GABAA receptor alterations in the human basal ganglia in Huntington\u2019s disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2007.07.009_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0014-2999(00)00682-8","article-title":"Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist","volume":"406","author":"Halldner","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2007.07.009_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.74.1.120","article-title":"Behavioural abnormalities contribute to functional decline in Huntington\u2019s disease","volume":"74","author":"Hamilton","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2007.07.009_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-4886(90)90014-J","article-title":"A primate model of Huntington\u2019s disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate\u2013putamen in the baboon","volume":"108","author":"Hantraye","year":"1990","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2007.07.009_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.07.009_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","article-title":"Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing","volume":"20","author":"Hickey","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2007.07.009_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington\u2019s disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2007.07.009_bib24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.07.009_bib25","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2007.07.009_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins and phosphorilation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2007.07.009_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2007.07.009_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2007.02.034","article-title":"Opposite effects of the A(2A) receptor agonist CGS21680 in the striatum of Huntington\u2019s disease versus wild-type mice","volume":"417","author":"Martire","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2007.07.009_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3758\/BF03200802","article-title":"The Observer Video-Pro: new software for the collection, management, and presentation of time-structured data from videotapes and digital media files","volume":"32","author":"Noldus","year":"2000","journal-title":"Behav. Res. Methods Instrum. Comput."},{"issue":"11 Suppl. 6","key":"10.1016\/j.nbd.2007.07.009_bib29","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1212\/01.WNL.0000095212.19029.04","article-title":"A2A receptors in neuroprotection of dopaminergic neurons","volume":"61","author":"Pedata","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2007.07.009_bib31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","article-title":"Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum","volume":"22","author":"Popoli","year":"2002","journal-title":"J. Neurosci."},{"issue":"11 Suppl 6","key":"10.1016\/j.nbd.2007.07.009_bib32","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1212\/01.WNL.0000095216.89483.A2","article-title":"Modulation of glutamate release and excitotoxicity by adenosine A2A receptors","volume":"61","author":"Popoli","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2007.07.009_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1615\/CritRevNeurobiol.v16.i12.110","article-title":"Adenosine A2A receptor antagonism and neuroprotection: mechanisms, lights, and shadows","volume":"16","author":"Popoli","year":"2004","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2007.07.009_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington\u2019s disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2007.07.009_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2006.10.004","article-title":"Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington\u2019s disease","volume":"176","author":"Scattoni","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2007.07.009_bib36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2007.07.009_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.20651","article-title":"Alterations in N-methyl-d-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington\u2019s disease","volume":"82","author":"Starling","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2007.07.009_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(99)00011-8","article-title":"Distribution, biochemistry and function of striatal adenosine A2A receptors","volume":"59","author":"Svenningsson","year":"1999","journal-title":"Progr. Neurobiol."},{"key":"10.1016\/j.nbd.2007.07.009_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A(2A) receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2007.07.009_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-2999(02)02148-9","article-title":"SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices","volume":"450","author":"Tebano","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2007.07.009_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jnr.20138","article-title":"Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum","volume":"77","author":"Tebano","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2007.07.009_bib41","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","article-title":"Aberrant amplification of A2A receptor signaling in striatal cells expressing mutant Huntingtin","volume":"15","author":"Varani","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2007.07.009_bib49","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","article-title":"Aberrant A2A receptor function in peripheral blood cells in Huntington\u2019s disease","volume":"17","author":"Varani","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2007.07.009_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker Francis","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2007.07.009_bib43","series-title":"New Statistical Procedures for the Social Sciences. Modern Solutions to Basic Problems","author":"Wilcox","year":"1987"},{"key":"10.1016\/j.nbd.2007.07.009_bib44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T08:45:13Z","timestamp":1556700313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996107001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0969996107001581"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2007.07.009","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}